Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine.
National and international regulations
Nuclear medicine
Quality assurance
Radiation protection
Theranostics guidelines
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
06 Feb 2024
06 Feb 2024
Historique:
received:
18
12
2023
accepted:
24
01
2024
medline:
6
2
2024
pubmed:
6
2
2024
entrez:
6
2
2024
Statut:
aheadofprint
Résumé
In the rapidly evolving field of nuclear medicine, the paramount importance of radiation protection, safety, and quality systems cannot be overstated. This document provides a comprehensive analysis of the intricate regulatory frameworks and guidelines, meticulously crafted and updated by national and international regulatory bodies to ensure the utmost safety and efficiency in the practice of nuclear medicine. We explore the dynamic nature of these regulations, emphasizing their adaptability in accommodating technological advancements and the integration of nuclear medicine with other medical and scientific disciplines. Audits, both internal and external, are spotlighted for their pivotal role in assessing and ensuring compliance with established standards, promoting a culture of continuous improvement and excellence. We delve into the significant contributions of entities like the International Atomic Energy Agency (IAEA) and relevant professional societies in offering universally applicable guidelines that amalgamate the latest in scientific research, ethical considerations, and practical applicability. The document underscores the essence of international collaborations in pooling expertise, resources, and insights, fostering a global community of practice where knowledge and innovations are shared. Readers will gain an in-depth understanding of the practical applications, challenges, and opportunities presented by these regulatory frameworks and audit processes. The ultimate goal is to inspire and inform ongoing efforts to enhance safety, quality, and effectiveness in nuclear medicine globally.
Sections du résumé
BACKGROUND
BACKGROUND
In the rapidly evolving field of nuclear medicine, the paramount importance of radiation protection, safety, and quality systems cannot be overstated. This document provides a comprehensive analysis of the intricate regulatory frameworks and guidelines, meticulously crafted and updated by national and international regulatory bodies to ensure the utmost safety and efficiency in the practice of nuclear medicine.
METHODS
METHODS
We explore the dynamic nature of these regulations, emphasizing their adaptability in accommodating technological advancements and the integration of nuclear medicine with other medical and scientific disciplines.
RESULTS
RESULTS
Audits, both internal and external, are spotlighted for their pivotal role in assessing and ensuring compliance with established standards, promoting a culture of continuous improvement and excellence. We delve into the significant contributions of entities like the International Atomic Energy Agency (IAEA) and relevant professional societies in offering universally applicable guidelines that amalgamate the latest in scientific research, ethical considerations, and practical applicability.
CONCLUSIONS
CONCLUSIONS
The document underscores the essence of international collaborations in pooling expertise, resources, and insights, fostering a global community of practice where knowledge and innovations are shared. Readers will gain an in-depth understanding of the practical applications, challenges, and opportunities presented by these regulatory frameworks and audit processes. The ultimate goal is to inspire and inform ongoing efforts to enhance safety, quality, and effectiveness in nuclear medicine globally.
Identifiants
pubmed: 38319322
doi: 10.1007/s00259-024-06633-w
pii: 10.1007/s00259-024-06633-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
International Atomic Energy Agency (IAEA). Radiation protection and safety of radiation sources: international basic safety standards. IAEA Safety Standards Series No. GSR Part 3. Vienna: IAEA. 2014. https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1578_web-57265295.pdf Last accessed 2 November 2023
Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, et al. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022;49:2300–9. https://doi.org/10.1007/s00259-022-05785-x .
doi: 10.1007/s00259-022-05785-x
pubmed: 35403861
pmcid: 9165261
Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, et al. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6:8. https://doi.org/10.1186/s41181-021-00123-2 .
doi: 10.1186/s41181-021-00123-2
pubmed: 33580358
pmcid: 7881071
Patt M, Decristoforo C, de Martini A, Koole M, Oyen WJG, Kiss OC. The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe. Eur J Nucl Med Mol Imaging. 2023;51(1):20–4. https://doi.org/10.1007/s00259-023-06472-1 .
doi: 10.1007/s00259-023-06472-1
pubmed: 37867178
pmcid: 10684671
European Association of Nuclear Medicine and Nuclear Medicine Europe joint statement on the revision of the European Pharmaceutical Legislation Time to Act for Nuclear Medicine. https://www.eanm.org/content-eanm/uploads/2023/10/EANM-NMEU-joint-communication-on-Pharma-Law.pdf . Accessed 2 Nov 2023.
Delgado Bolton RC, Giammarile F, Howlett DC, Jornet N, Brady AP, Coffey M, et al. The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe-the nuclear medicine perspective. Eur J Nucl Med Mol Imaging. 2023;50:2576–81. https://doi.org/10.1007/s00259-023-06203-6 .
doi: 10.1007/s00259-023-06203-6
pubmed: 37162511
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x .
Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 4th ed. Philadelphia: Saunders; 2012.
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with
doi: 10.1007/s00259-019-04485-3
pubmed: 31440799
Delgado Bolton RC, Aide N, Colletti PM, Ferrero A, Paez D, Skanjeti A, Giammarile F. EANM guideline on the role of 2-[
doi: 10.1007/s00259-021-05450-9
pubmed: 34215923
Adam JA, Loft A, Chargari C, Delgado Bolton RC, Kidd E, Schöder H, et al. EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0. Eur J Nucl Med Mol Imaging. 2021;48:1188–99. https://doi.org/10.1007/s00259-020-05112-2 .
doi: 10.1007/s00259-020-05112-2
pubmed: 33275178
Vaz SC, Adam JA, Delgado Bolton RC, Vera P, van Elmpt W, Herrmann K, et al. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. Eur J Nucl Med Mol Imaging. 2022;49:1386–406. https://doi.org/10.1007/s00259-021-05624-5 .
doi: 10.1007/s00259-021-05624-5
pubmed: 35022844
pmcid: 8921015
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM/SNMMI procedure guideline for the use of
doi: 10.1007/s00259-023-06255-8
pubmed: 37246997
pmcid: 10317889
Veit-Haibach P, Ahlström H, Boellaard R, Delgado Bolton RC, Hesse S, Hope T, et al. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Eur J Nucl Med Mol Imaging. 2023;50:3513–37. https://doi.org/10.1007/s00259-023-06406-x .
doi: 10.1007/s00259-023-06406-x
pubmed: 37624384
pmcid: 10547645
Beets G, Sebag-Montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, et al. ECCO essential requirements for quality cancer care: colorectal cancer. A critical review. Crit Rev Oncol Hematol. 2017;110:81–93. https://doi.org/10.1016/j.critrevonc.2016.12.001 .
doi: 10.1016/j.critrevonc.2016.12.001
pubmed: 28109408
Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol. 2017;110:94–105. https://doi.org/10.1016/j.critrevonc.2016.12.002 .
doi: 10.1016/j.critrevonc.2016.12.002
pubmed: 28109409
Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, et al. ECCO essential requirements for quality cancer care: melanoma. Crit Rev Oncol Hematol. 2018;122:164–78. https://doi.org/10.1016/j.critrevonc.2017.12.020 .
doi: 10.1016/j.critrevonc.2017.12.020
pubmed: 29458785
Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, et al. ECCO essential requirements for quality cancer care: oesophageal and gastric cancer. Crit Rev Oncol Hematol. 2018;122:179–93. https://doi.org/10.1016/j.critrevonc.2017.12.019 .
doi: 10.1016/j.critrevonc.2017.12.019
pubmed: 29458786
Brausi M, Hoskin P, Andritsch E, Banks I, Beishon M, Boyle H, et al. ECCO essential requirements for quality cancer care: prostate cancer. Crit Rev Oncol Hematol. 2020;148:102861. https://doi.org/10.1016/j.critrevonc.2019.102861 .
doi: 10.1016/j.critrevonc.2019.102861
pubmed: 32151466
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, et al. The requirements of a specialist breast centre. Breast. 2020;51:65–84. https://doi.org/10.1016/j.breast.2020.02.003 .
doi: 10.1016/j.breast.2020.02.003
pubmed: 32217457
pmcid: 7375681
Berghmans T, Lievens Y, Aapro M, Baird AM, Beishon M, Calabrese F, et al. European Cancer Organisation essential requirements for quality cancer care (ERQCC): lung cancer. Lung Cancer. 2020;150:221–39. https://doi.org/10.1016/j.lungcan.2020.08.017 .
doi: 10.1016/j.lungcan.2020.08.017
pubmed: 33227525
Delgado Bolton RC, Calapaquí Terán AK, Erba PA, Giammarile F. Medical imaging in times of pandemic: focus on the cornerstones of successful imaging. Eur J Nucl Med Mol Imaging. 2021;48:1724–5. https://doi.org/10.1007/s00259-021-05331-1 .
doi: 10.1007/s00259-021-05331-1
pubmed: 33770202
pmcid: 7994349
Thrall JH, Ziessman HA, Fahey FH. Nuclear medicine: the requisites. 5th ed. Philadelphia: Elsevier; 2021.
International Atomic Energy Agency (IAEA). Radiopharmaceuticals for positron emission tomography: production and quality control. IAEA-TECDOC-1607. Vienna: IAEA. 2008.
Sollini M, Gelardi F, Matassa G, Delgado Bolton RC, Chiti A, Kirienko M. Interdisciplinarity: an essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology. Rev Esp Med Nucl Imagen Mol. 2020;39:146–56. https://doi.org/10.1016/j.remn.2019.10.003 .
doi: 10.1016/j.remn.2019.10.003
pubmed: 32278786
Delgado Bolton RC, Calapaquí Terán AK, Fanti S, Giammarile F. New biomarkers with prognostic impact based on multitracer PET/CT imaging in neuroendocrine neoplasms: the light leading out of the darkness in challenging tumors. Clin Nucl Med. 2022;1(47):219–20. https://doi.org/10.1097/RLU.0000000000004062 .
doi: 10.1097/RLU.0000000000004062
Delgado Bolton RC, Calapaquí Terán AK, Fanti S, Giammarile F. The concept of strength through synergy applied to the search of powerful prognostic biomarkers in gastroesophageal cancer: an example based on combining clinicopathological parameters, imaging-derived sarcopenia measurements, and radiomic features. Clin Nucl Med. 2023;48:156–7. https://doi.org/10.1097/RLU.0000000000004357 .
doi: 10.1097/RLU.0000000000004357
pubmed: 35961366
Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD: radionuclide data and decay schemes. 2nd ed. Reston: Society of Nuclear Medicine; 2009.
Kayal G, Barbosa N, Marín CC, Ferrer L, Fragoso-Negrín JA, Grosev D, et al. Quality assurance considerations in radiopharmaceutical therapy dosimetry using PLANETDose: an international aAtomic energy agency study. J Nucl Med. 2024;65(1):125–31. https://doi.org/10.2967/jnumed.122.265340 .
Giammarile F, Muylle K, Delgado Bolton R, Kunikowska J, Haberkorn U, Oyen W. Dosimetry in clinical radionuclide therapy: the devil is in the detail. Eur J Nucl Med Mol Imaging. 2017;44:2137–9. https://doi.org/10.1007/s00259-017-3820-3 .
doi: 10.1007/s00259-017-3820-3
pubmed: 28891040
International Atomic Energy Agency. Nuclear medicine physics. Vienna: Non-serial Publications, IAEA; 2015.
Ma SX, Dhanaliwala AH, Rudie JD, Rauschecker AM, Roberts-Wolfe D, Haddawy P, Kahn CE Jr. Bayesian networks in radiology. Radiol Artif Intell. 2023;5(6):e210187. https://doi.org/10.1148/ryai.210187 .
doi: 10.1148/ryai.210187
pubmed: 38074791
pmcid: 10698603
Wendler T, Kreissl MC, Schemmer B, Rogasch JMM, De Benetti F. Artificial intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine. Nuklearmedizin. 2023;62(6):343–53. https://doi.org/10.1055/a-2200-2145 .
doi: 10.1055/a-2200-2145
pubmed: 37995707
pmcid: 10667065
Delbeke D, Segall GM. Status of and trends in nuclear medicine in the United States. J Nucl Med. 2011;52(suppl 2):24S-28S.
doi: 10.2967/jnumed.110.085688
pubmed: 22144551
International Atomic Energy Agency, Dosimetry for radiopharmaceutical therapy [IAEA preprint], [Link]. 2022. ( https://preprint.iaea.org/search.aspx?orig_q=RN:53037189 ) Last accessed 2 November 2023.
Almeida LS, Etchebehere ECSC, García Megías I, Calapaquí Terán AK, Hadaschik B, Colletti PM, et al. PSMA radioligand therapy in prostate cancer: where are we and where are we heading? Clin Nucl Med. 2024;49:45–55. https://doi.org/10.1097/RLU.0000000000004919 .
doi: 10.1097/RLU.0000000000004919
pubmed: 37882758
Goldsmith SJ. Targeted radionuclide therapy: a historical and personal review. Semin Nucl Med. 2020;50(1):87–97. https://doi.org/10.1053/j.semnuclmed.2019.07.006 .
doi: 10.1053/j.semnuclmed.2019.07.006
pubmed: 31843064
Pomykala KL, Hadaschik BA, Sartor O, Gillessen S, Sweeney CJ, Maughan T, Hofman MS, Herrmann K. Next generation radiotheranostics promoting precision medicine. Ann Oncol. 2023;34(6):507–19. https://doi.org/10.1016/j.annonc.2023.03.001 .
doi: 10.1016/j.annonc.2023.03.001
pubmed: 36924989